3030
Manuela Abreu, Sofia Barbosa, Ricardo Prata
15. Pacher P, Ungvari Z, Nanasi P, et al. Speculations on difference between tricyclic and se
lective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?
Curr Med Chem. 1999;6:469‑80.
16. Kantor SJ, Bigger JT Jr, Glassman AH, et al. Imipramine‑induced heart block. A longitudinal
case study. JAMA. 1975; 231: 1364‑6.
17. Vohra J, Burrows G, Hunt D, et al. The effect of toxic and therapeutic doses of tricyclic an
tidepressant drugs on intracardiac conduction. Eur J Cardiol. 1975;3:219‑27.
18. Giardina EG, Bigger JT jr, Glassman AH, et al. The electrocardiographic and antiarrhyth-
mic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation
1975;60:1045‑52.
19. Larsen KK, Agerbo E. myocardial infarction and risk of suicide: a population‑based case
control study. Circulation. 2010; 122: 2388‑2393.
20. Stahl SM. Antidepressants. In: Stahl SM ed. Stahl’s Essential Psychopharmacology. Neuros-
cientific Basis and Practical Applications, 4
th
edition, chapter 7. Cambridge University Press;
2013: 284‑369.
21. Pal Pacher, Valeria Kecskemeti. Cardiovascular Side Effects of New Antidepressants and
Antipsychotics: New Drugs, old Concerns?. Curr Pharm Des. 2004; 10: 2463‑2475.
22. Taylor D., Paton C., Kapur S. The Maudsley Prescribing Guidelines, 10th edition London:
Informa Healthcare 2009.
23. Fisch C. Effect of fluoxetine on electrocardiogram. J Clin Psychiatry. 1985; 46:42‑4
24. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed
patients with heart disease. Am J Psychiatry. 1998; 155:660‑5.
25. Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of
patients with major depression after first myocardial infarction: findings from a double‑blind,
placebo‑controlled trial. Psychosom Med. 2000; 62:783‑9.
26. Kuhs H, Rudolf GA E. Cardiovascular effects of paroxetine. Psychopharmacology. 1990;
102:379‑82.
27. Shapiro PA, Lesperance F, Frasure‑Smith N, et al. An open‑label preliminary trial of sertra-
line for treatment of major depression after acute myocardial infarction (the SADHAT Trial).
Sertraline Anti‑Depressant Heart Attack Trial. Am Heart J. 1999; 137: 1100‑6.
28. Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in
patients with acute MI or unstable angina. JAMA. 2002; 288: 701‑9.
29. Jiang W, O’Connor C, Silva SG, et al. Safety and efficacy of sertraline for depression in
patients with CHF (SADHART‑CHF): a randomized, double‑blind, placebo‑controlled
trial of sertraline for major depression with congestive heart failure. Am Heart J. 2008;
156:437‑44.
